A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis
- 1 June 1995
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 16 (6), 179-181
- https://doi.org/10.1016/s0165-6147(00)89018-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Recent Advances: Cardiology - I: Treatment of myocardial infarction, unstable angina, and angina pectorisBMJ, 1994
- FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T‐purinoceptorsBritish Journal of Pharmacology, 1994
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapyBMJ, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Fibrinogen receptor antagonists - a novel class of promising antithromboticsDrugs of the Future, 1994
- New Antithrombotic Strategies for Resistant Thrombotic ProcessesThe Journal of Clinical Pharmacology, 1994
- Low molecular weight, non-peptide fibrinogen receptor antagonistsJournal of Medicinal Chemistry, 1992
- ADENOSINE 5′‐DIPHOSPHATE ANTAGONISTS AND HUMAN PLATELETS: NO EVIDENCE THAT AGGREGATION AND INHIBITION OF STIMULATED ADENYLATE CYCLASE ARE MEDIATED BY DIFFERENT RECEPTORSBritish Journal of Pharmacology, 1982
- SPECIFIC BUT NONCOMPETITIVE INHIBITION BY 2‐ALKYLTHIO ANALOGUES OF ADENOSINE 5′‐MONOPHOSPHATE AND ADENOSINE 5′‐TRIPHOSPHATE OF HUMAN PLATELET AGGREGATION INDUCED BY ADENOSINE 5′‐DIPHOSPHATEBritish Journal of Pharmacology, 1982